Atlas Trials

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Clinical trial NCT02857517 · UNKNOWN

Trial details

NCT number
NCT02857517
Sponsor
Jiao Mingfei
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Choroidal Neovascularization
Start date
2016-06-01
Primary completion
2018-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.